Hormonal mechanisms of memory  T cellules.

These theme is coming back a lot. About rejection and how hormonal balance was invented to this purpose and effect. (On going)

There is a draft of a scientific letter. It is written in a formal tone suitable for submission to a medical journal like the Journal of Heart and Lung Transplantation or American Journal of Transplantation. It assumes a basic understanding of transplant immunology.

---

[Your Name/Institution Name]
[Your Address]
[Your Email/Phone Number]
[Date]

The Editor
[Journal Name]
[Journal Address]

Re: Modulation of tissue-resident memory T cells by glucocorticoids after acute cellular rejection in lung transplantation

Dear Editor,

The treatment of acute cellular rejection (ACR) in lung transplantation relies heavily on high-dose glucocorticoids. While effective at reversing clinical and histological rejection in the short term, the mechanisms by which steroids influence the long-term graft immune landscape, particularly the population of tissue-resident memory T cells (T_RM), remain underexplored. We read with great interest recent work highlighting the dual role of T_RM cells in mediating rapid on-site protection against pathogens while also contributing to chronic allograft rejection [1, 2]. We hypothesize that glucocorticoid pulse therapy, beyond its immediate lympholytic effects, fundamentally alters the establishment and function of the T_RM niche within the lung allograft.

T_RM cells are characterized by their expression of markers such as CD69, CD103, and the transcription factor Hobit. Unlike circulating memory T cells, they persist in barrier tissues and provide rapid, frontline immune responses. In lung transplantation, donor-reactive T_RM cells are believed to be significant drivers of chronic lung allograft dysfunction (CLAD), particularly bronchiolitis obliterans syndrome [3]. The current standard of care for ACR—intravenous methylprednisolone—induces profound T-cell apoptosis and alters chemokine receptor expression. However, its specific impact on the CD69⁺CD103⁺ T_RM population, which resides in the epithelial and submucosal compartments, is likely distinct from its effect on circulating T cells.

We propose that glucocorticoid treatment modulates the pulmonary T_RM pool through at least three distinct, non-mutually exclusive mechanisms:

1. Disruption of the Survival Niche: T_RM persistence is dependent on local survival signals, including IL-15 and TGF-β. High-dose glucocorticoids can downregulate cytokine receptor signaling and alter the function of airway epithelial cells—the very cells that provide the survival niche for CD103⁺ T_RM cells [4]. By disrupting this niche, steroids may reduce the longevity of existing graft-resident populations.
2. Altered Recruitment and Retention: Glucocorticoids potently inhibit the expression of inflammatory chemokines (such as CXCL9, CXCL10) and adhesion molecules. This not only halts the infiltration of circulating effector T cells during the rejection event but may also prevent the recruitment of circulating precursors that could replenish the T_RM pool after the resolution of inflammation.
3. Differential Transcriptional Reprogramming: While steroids induce apoptosis in activated T cells, surviving T cells undergo significant transcriptional reprogramming. The glucocorticoid receptor (GR) can directly interfere with transcription factors critical for T_RM differentiation, such as Runx3 and Blimp-1. This interference may push the balance of alloreactive cells away from a tissue-resident fate and toward a central memory or exhausted phenotype.

The clinical implication of this modulation is significant. Aggressive steroid pulses may inadvertently deplete protective viral-specific T_RM cells, increasing the risk of community-acquired respiratory viruses (CARVs) post-rejection. Conversely, if steroid-resistant alloreactive T_RM clones persist, they could serve as a reservoir for future episodes of rejection or the development of CLAD.

Future Directions:
We advocate for a multi-omics approach using serial transbronchial biopsies and bronchoalveolar lavage samples from patients treated for ACR. Single-cell RNA sequencing (scRNA-seq) could map the transcriptional trajectory of T_RM cells pre- and post-steroid pulse. Furthermore, spatial transcriptomics could reveal if steroids alter the physical proximity and interaction between residual T_RM cells and the airway epithelium. Understanding whether current steroid regimens successfully clear alloreactive T_RM cells or simply induce a state of reversible quiescence is crucial for developing targeted therapies to prevent CLAD while preserving anti-pathogen immunity.

Sincerely,

[Your Name], [Your Credentials, e.g., MD, PhD]
[Department, Institution]

References:

1. Snyder, M.E., et al. (2021). Generation and persistence of human tissue-resident memory T cells in lung transplantation. Science Immunology.
2. Mueller, S.N. and Mackay, L.K. (2016). Tissue-resident memory T cells: local specialists in immune defence. Nature Reviews Immunology.
3. Kalscheuer, H., et al. (2019). Tissue-resident memory T cells in chronic lung allograft dysfunction. American Journal of Transplantation.
4. Van Kaer, L., et al. (2022). Effects of glucocorticoids on the development and function of tissue-resident lymphocytes. Frontiers in Immunology.